Ideas

Molecular therapy for inflammation and arthritis:  Lidocaine (brand name: xylocaine and lignocaine), a drug used to treat numb tissue and ventricular tachycardia, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 4/October/2018, 6.41 pm

Molecular therapy for inflammation and arthritis:  Lidocaine (brand name: xylocaine and lignocaine), a drug used to treat numb tissue and ventricular tachycardia, increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis, via up-regulation of its target genes, 4/October/2018, 6.41 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that “Resolution of inflammation by…

read more

Induction of the PD-1 pathway for Pain therapy:  Nerve growth factor (NGF)  increases the expression of PD-L1, attenuates acute and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gene, 4/October/2018, 6.02 pm

Induction of the PD-1 pathway for Pain therapy:  Nerve growth factor (NGF)  increases the expression of PD-L1, attenuates acute and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gene, 4/October/2018, 6.02 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction:What they say: A recent study from Institute of Neurobiology, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Collaborative Innovation Center for Brain Science, Fudan University, Shanghai,…

read more

Awakening the sleeping/cancer-protecting angels in mutant p53-expressing human tumors: Act1 (Adaptor for IL-17 receptors) increases the expression of tumor suppressors genes, such as ANP32A, VHL, p53,  p53, TAp63, TAp73, INK4a/ARF, and others, induces regression of p53-mutated human tumors, via down-regulation of its target gene, 2/October/2018, 11.56 pm

Awakening the sleeping/cancer-protecting angels in mutant p53-expressing human tumors: Act1 (Adaptor for IL-17 receptors) increases the expression of tumor suppressors genes, such as ANP32A, VHL, p53,  p53, TAp63, TAp73, INK4a/ARF, and others, induces regression of p53-mutated human tumors, via down-regulation of its target gene, 2/October/2018, 11.56 pm 960 720 Dr Boomi's Genom-2-Discovery Center

On the eve of Mahatma Gandhi Birth Anniversary We wish everyone a happy Mahatma Gandhi Jayanti 2018. On this special occasion, we are happy to announce that Ideas posted today (02/October/2018) will be available to the use…

read more

Molecular therapy for autoimmune diabetes (TIDM): Carbamazepine, an anticonvulsant drug used to treat  seizures and nerve pain such as trigeminal neuralgia and diabetic neuropathy, and bipolar disorder, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 2/October/2018, 11.48 pm

Molecular therapy for autoimmune diabetes (TIDM): Carbamazepine, an anticonvulsant drug used to treat  seizures and nerve pain such as trigeminal neuralgia and diabetic neuropathy, and bipolar disorder, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up-regulation of its target gene, 2/October/2018, 11.48 pm 960 720 Dr Boomi's Genom-2-Discovery Center

On the eve of Mahatma Gandhi Birth Anniversary We wish everyone a happy Mahatma Gandhi Jayanti 2018. On this special occasion, we are happy to announce that Ideas posted today (02/October/2018) will be available to the use…

read more

Awakening the sleeping/cancer-protecting angels in mutant p53-expressing human tumors: Mibolerone (Trade name: Cheque drops and Matenon), an anabolic-androgenic steroid, increases the expression of tumor suppressors genes, such as ANP32A, VHL, p53,  p53, TAp63, TAp73, INK4a/ARF, and others, induces regression of p53-mutated human tumors, via down-regulation of its target gene, 2/October/2018, 11.36 pm

Awakening the sleeping/cancer-protecting angels in mutant p53-expressing human tumors: Mibolerone (Trade name: Cheque drops and Matenon), an anabolic-androgenic steroid, increases the expression of tumor suppressors genes, such as ANP32A, VHL, p53,  p53, TAp63, TAp73, INK4a/ARF, and others, induces regression of p53-mutated human tumors, via down-regulation of its target gene, 2/October/2018, 11.36 pm 960 720 Dr Boomi's Genom-2-Discovery Center

On the eve of Mahatma Gandhi Birth Anniversary We wish everyone a happy Mahatma Gandhi Jayanti 2018. On this special occasion, we are happy to announce that Ideas posted today (02/October/2018) will be available to the use…

read more

Nicotine-based therapy for autoimmune diabetes (TIDM): Nicotine, the major components of cigarettes, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 2/October/2018, 11.26 pm

Nicotine-based therapy for autoimmune diabetes (TIDM): Nicotine, the major components of cigarettes, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 2/October/2018, 11.26 pm 960 720 Dr Boomi's Genom-2-Discovery Center

On the eve of Mahatma Gandhi Birth Anniversary We wish everyone a happy Mahatma Gandhi Jayanti 2018. On this special occasion, we are happy to announce that Ideas posted today (02/October/2018) will be available to the use…

read more